Cross Country Healthcare Inc (CCRN)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $428.06M
Last updated: Jul 22, 2026 at 5:00 PM ET
Cross Country Healthcare Inc (CCRN) Financials: Revenue, Profit and Cash Flow
Cross Country Healthcare reported revenue of $1.05B for the fiscal year ended Dec 31, 2025, down 21.6% from the year before. That year, net income was -$94.85M with a net margin of -9.0%, operating cash flow was $48.25M and free cash flow was $40.09M. The quarter ended Mar 31, 2026 had revenue of $241.06M and net income of -$4.27M.
Revenue and Margins
The operating margin was -8.0% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $833.54M, a compound annual rate of 2.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.05B | -21.6% | 20.3% | -8.0% | -9.0% |
| Dec 2024 | $1.34B | -33.5% | 98.4% | -1.3% | -1.1% |
| Dec 2023 | $2.02B | -28.0% | 99.3% | 5.6% | 3.6% |
| Dec 2022 | $2.80B | +67.2% | 99.7% | 9.6% | 6.6% |
| Dec 2021 | $1.68B | +100.5% | 22.4% | 8.3% | 7.9% |
| Dec 2020 | $836.42M | +1.7% | 99.6% | -1.1% | -1.5% |
| Dec 2019 | $822.22M | +0.7% | 99.8% | -1.9% | -6.8% |
| Dec 2018 | $816.48M | -5.6% | 99.7% | -1.6% | -1.9% |
| Dec 2017 | $865.05M | +3.8% | 99.8% | 1.4% | 4.5% |
| Dec 2016 | $833.54M | N/A | 99.9% | 0.7% | 1.0% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Mar 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.05B | $1.34B | $2.02B | $2.80B | $1.68B | $836.42M | $822.22M | $816.48M | $865.05M | $833.54M |
| Cost of revenue | $840.72M | $21.43M | $14.56M | $9.61M | $1.30B | $3.04M | $2.01M | $2.20M | $1.83M | $593.00K |
| Gross profit | $213.57M | $1.32B | $2.01B | $2.79B | $375.00M | $833.38M | $820.22M | $814.28M | $863.22M | $832.94M |
| Operating income | -$84.41M | -$16.86M | $112.71M | $269.88M | $139.30M | -$9.16M | -$15.71M | -$12.88M | $11.75M | $6.18M |
| Net income | -$94.85M | -$14.56M | $72.63M | $185.98M | $132.00M | -$12.14M | -$55.94M | -$15.72M | $38.80M | $8.73M |
| EBITDA | -$67.63M | $1.94M | $130.97M | $283.78M | $149.93M | $3.23M | -$2.85M | -$682.00K | $24.31M | $23.13M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $241.06M | $236.76M | $250.05M | $274.07M | $293.41M | $309.94M | $315.12M | $339.77M | $379.17M | $414.04M | $442.29M | $540.70M |
| Gross profit | $241.00M | -$604.76M | $250.91M | $274.04M | $293.37M | $310.17M | $313.61M | $320.91M | $377.88M | $409.87M | $439.94M | $537.56M |
| Operating income | -$4.16M | -$71.61M | -$5.97M | -$5.86M | -$977.00K | -$3.43M | $2.85M | -$19.21M | $2.92M | $13.42M | $20.30M | $35.19M |
| Net income | -$4.27M | -$82.93M | -$4.77M | -$6.66M | -$490.00K | -$3.75M | $2.56M | -$16.05M | $2.69M | $9.04M | $12.81M | $21.34M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $1.16M by $107.58M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $448.95M | $589.25M | $681.06M | $949.59M | $732.81M | $356.97M | $382.37M | $427.00M | $467.69M | $388.38M |
| Current assets | $293.59M | $335.00M | $416.88M | $677.39M | $508.27M | $183.11M | $183.36M | $194.91M | $208.89M | $205.61M |
| Cash and equivalents | $108.74M | $81.63M | $17.09M | $3.60M | $1.04M | $1.60M | $1.03M | $16.02M | $25.54M | $20.63M |
| Total liabilities | $126.13M | $170.29M | $213.41M | $498.11M | $435.28M | $202.06M | $218.87M | $208.81M | $229.97M | $236.58M |
| Short-term debt | $1.16M | $4.41M | $6.79M | $7.50M | $11.68M | $2.42M | $4.88M | $5.24M | $6.88M | $2.25M |
| Long-term debt | N/A | N/A | N/A | $148.74M | $176.37M | $53.41M | $70.97M | $77.94M | $92.26M | $84.75M |
| Shareholder equity | $322.82M | $418.96M | $467.65M | $451.48M | $297.53M | $154.38M | $162.63M | $217.53M | $237.09M | $151.24M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $451.07M | $448.95M | $538.23M | $553.82M | $576.24M | $589.25M | $597.42M | $602.88M | $648.44M | $679.32M | $707.74M | $771.13M |
| Total liabilities | $138.27M | $126.13M | $130.09M | $141.58M | $158.03M | $170.29M | $172.73M | $163.82M | $180.25M | $205.92M | $238.08M | $300.78M |
| Cash and equivalents | $105.58M | $108.74M | $99.13M | $81.19M | $80.70M | $81.63M | $64.02M | $69.60M | $5.24M | $17.09M | $14.30M | $673.00K |
| Shareholder equity | $312.81M | $322.82M | $408.14M | $412.24M | $418.21M | $418.96M | $424.69M | $439.06M | $468.19M | $473.39M | $469.66M | $470.35M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 83.1% of operating cash flow. Share repurchases came to 17.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $48.25M | $120.12M | $248.50M | $134.05M | -$85.62M | $27.20M | $5.54M | $21.00M | $45.51M | $30.14M |
| Capital expenditures | $8.16M | $8.71M | $13.97M | $8.79M | $7.17M | $4.62M | $2.94M | $4.60M | $5.11M | $6.52M |
| Free cash flow | $40.09M | $111.40M | $234.52M | $125.26M | -$92.79M | $22.59M | $2.60M | $16.40M | $40.40M | $23.62M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $1.15M | $1.57M | $1.19M | $1.22M | $701.00K |
| Share repurchases | $6.83M | $37.31M | $57.65M | $35.28M | $0 | $0 | N/A | $5.00M | $0 | $0 |
| Investing cash flow | -$8.16M | -$8.71M | -$13.78M | -$43.87M | -$34.05M | -$4.62M | -$2.94M | -$6.68M | -$91.38M | -$9.78M |
| Financing cash flow | -$13.01M | -$46.85M | -$221.24M | -$87.60M | $119.09M | -$22.01M | -$17.60M | -$23.77M | $50.76M | -$2.16M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.77M | $18.24M | $20.11M | $4.22M | $5.68M | $24.23M | $7.47M | $82.40M | $6.01M | $12.07M | $70.31M | $119.25M |
| Capital expenditures | $1.46M | $2.12M | $2.19M | $1.97M | $1.89M | $2.53M | $1.12M | $2.85M | $2.21M | $2.88M | $3.42M | $4.00M |
| Free cash flow | $3.31M | $16.12M | $17.92M | $2.25M | $3.79M | $21.70M | $6.35M | $79.55M | $3.80M | $9.20M | $66.89M | $115.25M |
Frequently Asked Questions About CCRN
What is Cross Country Healthcare's annual revenue?
Cross Country Healthcare reported revenue of $1.05B for the fiscal year ended Dec 31, 2025.
How fast is Cross Country Healthcare's revenue growing?
Revenue was down 21.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -27.8%.
Is Cross Country Healthcare profitable?
No. Cross Country Healthcare reported net income of -$94.85M for the fiscal year ended Dec 31, 2025, with a net margin of -9.0%.
How much free cash flow does CCRN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $48.25M minus capital expenditures of $8.16M produced free cash flow of $40.09M.
How much debt does Cross Country Healthcare have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $1.16M and cash and equivalents of $108.74M.
CCRN pages: Overview, Financials, Government Contracts